ASTMH 2015

[October 25-29, 2015]

American Society of Tropical Medicine and Hygiene (ASTMH), 64th Annual Meeting
Philadelphia, United States

ASTMH, founded in 1903, is a worldwide organization of scientists, clinicians and program professionals whose mission is to promote global health through the prevention and control of infectious and other diseases that disproportionately afflict the global poor. Research, health care and education are the central activities of ASTMH members, whose work bridges basic laboratory research to international fieldwork and clinics to country-wide programs.

The Annual Meeting is a dynamic forum for the exchange of the latest scientific and clinical advances in tropical medicine and global health.

DNDi Medical Director, Nathalie Strub Wourgaft, spoke in a session on clinical experience in treating neglected infectious tropical diseases.

COST 2015

[October 26-28, 2015]
European Cooperation in Science and Technology
Belgrade, Serbia
Jean-Robert Ioset, Discovery Manager, DNDi presented on drug discovery against kinetoplastid diseases.

World Health Summit

[October 11-13, 2015]
Berlin, Germany
DNDi`s Business Development Director, Jean-Pierre Paccaud co-chaired a workshop entitled: “Global Health Research for Development”.


[October 09-11, 2015]
Patna, India
Dr Suman Rijal, Director of DNDi Regional Office India, presented on the challenges for diagnosis in visceral leishmaniasis

REINVENT: Conference on Neglected Diseases

[October 2, 2015]
Toronto, Canada
Rachel Cohen, Regional Executive Director of DNDi North America spoke in a session entitled: “Free Trade at What Cost? R&D for Neglected Diseases”.

Strategic Orientations: DNDi Business Plan 2015-2023

[September 07, 2015]
Basel, Switzerland
On the occasion of the 9th European Congress on Tropical Medicine and International Health (ECTMIH) in Basel, Switzerland, DNDi hosted a Stakeholders’ Event to launch DNDi `s new Business Plan, 2015-2023.


[September 6-10, 2015]
9th European Congress on Tropical Medicine and International Health
Basel, Switzerland
DNDi presented in symposia and poster sessions on visceral leishmaniasis, open source drug discovery, Chagas disease, helminth infections, sleeping sickness, ebola, and mycetoma.

ICC Leish 2015

[August 10-13, 2015]
International Conference on Cutaneous Leishmaniasis
Manaus, Brazil
DNDi ‘s Head of Cutaneous Leishmaniasis, Byron Arana, presented on clinical trial methodology and DNDi‘s CL strategy. Clinical Trial Manager, Joelle Rode, presented about Rede Leish.

11th Liver Update 2015

[July 30 – August 2, 2015]
Selangor, Malaysia
DNDi presented in a plenary and a symposium on hepatitis C.

UNITAID Stakeholders Briefing

[July 21, 2015]
Accelerating Innovation for Pediatric ARV Formulations: Review of Progress of Mutual Accountability Framework
Vancouver, Canada
DNDi‘s Head of Paediatric HIV Programme, Marc Lallemant, took part in a high-­level panel discussion on overcoming challenges and advancing opportunities to accelerate product innovation and market uptake of new pediatric ARV formulations.

Medtrop 2015

[June 14-17, 2015]
Doenças tropicais: do ensino e pesquisa aos serviços de saúde
Ceará, Brazil
DNDi presented at sessions on Chagas disease and leishmaniasis.

ISNTD d3 2015

[May 20-21, 2015]
London, United Kingdom
DNDi presented on drug discovery for leishmaniasis and Chagas disease.